Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.7B | 11.2B | 9.8B | 12.7B |
Cost of revenue | 7.3B | 8.8B | 7.6B | 9.5B |
Gross profit | 1.5B | 2.4B | 2.2B | 3.1B |
Operating expense | ||||
Research & development | — | 266.3M | 252.2M | 216.2M |
Selling general and admin | 1.3B | 142.7M | 167.0M | 152.4M |
Other operating expenses | — | 30.0M | 25.8M | 27.6M |
Operating income | 1.5B | 1.2B | 968.5M | 1.9B |
Non operating interest income | ||||
Income | — | 255.2M | 217.2M | 186.1M |
Expense | — | 6.6M | 7.3M | 40.3M |
Other income expense | — | — | — | — |
Pretax income | 580.8M | 1.4B | 1.3B | 2.1B |
Tax provision | 149.0M | 114.6M | 142.1M | 300.2M |
Net income | 431.8M | 1.3B | 1.2B | 1.8B |
Basic EPS | 46.6 | — | 127 | 192 |
Diluted EPS | 46.6 | — | 127 | 191 |
Basic average shares | — | — | 9.3M | 9.3M |
Diluted average shares | — | — | 9.3M | 9.3M |
EBITDA | 1.5B | 1.7B | 1.6B | 2.4B |
Net income from continuing op. | — | 1.3B | 1.2B | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |